Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01504152 · ClinicalTrials.gov registry record

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
519
Enrollment target

NCT01504152: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01504152 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 519 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01504152 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
519 participants
Enrollment target

Study Summary

The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.

Primary Outcome

of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT

Interventions

  • BEHAVIORAL questionnaire

Trial Details

FieldValue
Enrollment Target 519 participants
Start Date 2011-12
Est. Completion 2013-07
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT01504152 record still lists

NCT01504152 is an observational study that tracks outcomes without assigning an intervention. The registered 519 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.

NCT01504152 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01504152 about?

NCT01504152 is a clinical study titled "International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center". The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to prov...

What is the current status of trial NCT01504152?

This trial is currently completed. The enrollment target is 519 participants. The study started on 2011-12. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01504152?

The interventions under investigation include: questionnaire (BEHAVIORAL).

Who is sponsoring clinical trial NCT01504152?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323581 · 520 participants · NA

    Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

  • NCT04656496 · 520 participants · NA

    NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

  • NCT05445778 · 520 participants · Phase 3

    Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

  • NCT05498428 · 520 participants · Phase 2

    A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01504152, the US trial registry maintained by the National Library of Medicine. NCT01504152 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.